Letter to the Editor

Prevalence of Xerostomia in Patients Referred to Shiraz Dental School, Shiraz, Iran during 2006-2013

Abstract

Prevalence of Xerostomia in Patients Referred to Shiraz Dental School, Shiraz, Iran during 2006-2013

Almeida Pdel V, Grégio AM, Machado MA, Lima AA, Azevedo LR (2008). Saliva composition and functions: a comprehensive review. J Contemp Dent Pract, 9(3):72-80.

Nagler RM (2004). Salivary glands and the aging process: mechanistic aspects, health-status and medicinal-efficacy monitoring. Biogerontology, 5(4):223-33.

Davies AN, Shorthose K (2007). Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy. Cochrane Database Syst Rev, 18(3):CD003782.

Boyce HW, Bakheet MR (2005). Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease. J Clin Gastroenterol, 39(2):89-97.

Fox PC, Busch KA, Baum BJ (1987). Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc, 115(4): 581-4.

Lončar M, Mravak-Stipetić M, Risović D (2011). The effect of low level lasertherapy on salivary glands in patients with xerostomia. Photomed Laser Surg, 29(3):171-5.

Mozafari PM1, Dalirsani Z, Delavarian Z, Amirchaghmaghi M, Shakeri MT, Esfandyari A, Falaki F (2012). Prevalence of oral mucosal lesions in institutionalized elderly people in Mashhad, Northeast Iran. Gerodontology, 29(2):e930-4.

Nederfors T (1996). Xerostomia: Prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists. Swed Dent J Suppl, 116: 1-70.

Files
IssueVol 45 No 12 (2016) QRcode
SectionLetter to the Editor
Keywords
No keywords##
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
GHAPANCHI J, REZAZADEH F, FAKHRAEE E, ZAMANI A. Prevalence of Xerostomia in Patients Referred to Shiraz Dental School, Shiraz, Iran during 2006-2013. Iran J Public Health. 2016;45(12):1665-1666.